Username Password
S&P 500: 1,070.52 Change: +1.30%

BIOGEN IDEC INC (BIIB)

Overview
Price $54.09
Price change for today in $ +$1.25
Price change for today in % +2.37%
P&P rating Rating: 3
Open Price
Previous close $52.84
Daily Range $53.33 - $54.88
52-Week Range $41.75 - $55.37
Volume 2,964,960
chart
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

48 Buy
0 Sell
 
Top Buy Analysis
BUY: BIIB Rating: 3
Company: BIOGEN IDEC INC
Points: 19.83
Start Price: $52.47
Start Date: 08/12/2008 6:12 PM
2dimes
2dimes
P&P Score: 20.29
Recs:
Recent negative price gap due to possible side effects of Multiple Sclerosis Drug Tysabri will be resolved near term allowing price Target of 75 near term and 95 in 1st quarter 2009

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
JDShots 0.02 BUY Week or Less 02/24/2009 $50.55 $54.09
(+2.37%)
+7.00% +39.96% -32.95 view
2dimes 20.29 BUY One to Three Months 08/12/2008 $52.47 $54.09
(+2.37%)
+3.09% -16.74% +19.83 view
LeveneOMurray 99.96 BUY Week or Less 06/26/2008 $56.34 $54.09
(+2.37%)
-3.99% -16.57% +12.58
ryno8888 13.93 BUY Six Months to a Year 04/27/2008 $64.67 $54.09
(+2.37%)
-16.36% -23.34% +6.98
bella 12.70 BUY Three to Six Months 04/03/2008 $62.94 $54.09
(+2.37%)
-14.06% -21.72% +7.66
band6 BUY Week to a Month 03/24/2008 $61.46 $54.09
(+2.37%)
-11.99% -20.70% +8.70 view
Phil Smith 87.01 BUY Six Months to a Year 01/01/2008 $46.78 $54.09
(+2.37%)
+15.63% -27.07% +42.70
RJ44 68.32 BUY Six Months to a Year 01/01/2008 $46.26 $54.09
(+2.37%)
+16.93% -27.07% +44.00
pharma 78.53 BUY Six Months to a Year 01/01/2008 $44.83 $54.09
(+2.37%)
+20.66% -27.07% +47.73
Reames405 88.37 BUY Six Months to a Year 01/01/2008 $43.82 $54.09
(+2.37%)
+23.44% -27.07% +50.51
Pages: [ 1 ]  2   3   4   5  >>
Commentary
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $50.55
Points: -32.95
Created: 02/24/2009
Recommended by Zacks

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $52.47
Points: +19.83
Created: 08/12/2008
Recent negative price gap due to possible side effects of Multiple Sclerosis Drug Tysabri will be resolved near term allowing price Target of 75 near term and 95 in 1st quarter 2009

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $61.46
Points: +8.70
Created: 03/24/2008
great buyout---but could be very sucessful on its own.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $56.34
Points: +12.58
Created: 06/26/2008

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $64.67
Points: +6.98
Created: 04/27/2008

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $62.94
Points: +7.66
Created: 04/03/2008

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $46.78
Points: +42.70
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $46.26
Points: +44.00
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $44.83
Points: +47.73
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 3
Start Price: $43.82
Points: +50.51
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5  >>
Sponsored Links